Search

Hutchison China MediTech Ltd ADR

Aperta

SettoreSettore sanitario

10.96 0.09

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

10.34

Massimo

11

Metriche Chiave

By Trading Economics

Entrata

978K

Vendite

135M

P/E

Media del settore

4.272

62.58

Margine di Profitto

0.722

Dipendenti

1,796

EBITDA

-14M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+35.06% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.9B

Apertura precedente

10.87

Chiusura precedente

10.96

Notizie sul Sentiment di mercato

By Acuity

100%

0%

319 / 340 Classifica in Healthcare

Hutchison China MediTech Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 lug 2026, 23:51 UTC

News

Tenet Healthcare reported second-quarter earnings of $6.12 per share, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

24 lug 2026, 23:46 UTC

News

HF Sinclair Corp has filed a lawsuit against the EPA over biofuel blending delays. Shares rose during after-market hours, maintaining a strong monthly performance.

24 lug 2026, 23:41 UTC

News

Kinsale Capital Group reported Q2 earnings of $5.54 per share, exceeding estimates, with revenue of $548.5 million, driving shares higher in after-market trading.

24 lug 2026, 23:41 UTC

Macro News
ETF Constituents
News

The Vanguard Information Technology ETF is higher in after-market hours, supported by key holdings like Apple and Qualcomm, despite broader market declines.

24 lug 2026, 23:41 UTC

News

Datadog Inc. is higher in after-market trading, benefiting from steady quarter-over-quarter revenue growth despite being surpassed by CoreWeave in total revenue.

24 lug 2026, 23:41 UTC

News

Boeing Co shares advanced in after-market hours, supported by a $695 billion backlog and positive analyst outlook on growth potential.

24 lug 2026, 23:36 UTC

News

KKR & Co Inc shares are lower in after-market hours following a $238.954 million share sale, reflecting potential liquidity concerns and capital allocation shifts.

24 lug 2026, 23:31 UTC

News

Interactive Brokers Group reported a 77% pre-tax profit margin but shares are lower in after-market hours amid concerns over rising interest rates and profitability.

24 lug 2026, 23:21 UTC

News
Social Media

Micron Technology Inc shares are declining in after-market trading amid concerns over potential pricing pressures in the cyclical memory chip market.

24 lug 2026, 23:21 UTC

Social Media
News

Warner Bros Discovery shares are lower in after-market trading as merger plans with Paramount Skydance are postponed until June 2027 amid legal challenges.

24 lug 2026, 23:21 UTC

News

Baker Hughes Co shares rose in after-market hours after a decrease in the active rig count, which fell to 587, the lowest since mid-July.

24 lug 2026, 23:16 UTC

News

CS PowerTech has launched its photovoltaic cell facility in Indiana, boosting Canadian Solar's U.S. manufacturing capabilities. Shares are higher in after-market trading.

24 lug 2026, 23:16 UTC

News

Liberty Energy reported Q2 revenue of $1.19 billion, exceeding estimates. Shares are higher in after-market trading following the earnings release.

24 lug 2026, 23:06 UTC

News

American Airlines Group Inc shares are lower in after-market hours following weaker profit guidance for the third quarter amid rising fuel costs.

24 lug 2026, 23:01 UTC

ETF Constituents
News

Vanguard Growth ETF advances in after-market trading, supported by contributions from Apple, Uber, and Applied Materials, following three lower daily closes.

24 lug 2026, 23:01 UTC

News

Elme Communities announced property sales totaling $294 million and revised liquidating distributions to $16.41 to $16.61 per share, trading higher in after-market hours.

24 lug 2026, 23:01 UTC

News

CACI International Inc. shares declined in after-market trading, influenced by a downturn in the Research & Consulting Services sub-sector.

24 lug 2026, 23:01 UTC

News

Emerson Electric Co shares are lower in after-market trading amid mixed market sentiment influenced by geopolitical tensions and new tariffs from the Trump administration.

24 lug 2026, 23:01 UTC

News

Carrier Global Corp shares declined in after-market hours following the appointment of PTC's Neil Barua to its board, effective immediately.

24 lug 2026, 23:01 UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

24 lug 2026, 22:22 UTC

News
Social Media

Uber shares are higher in after-market hours amid intensifying discussions about its partnership with Waymo and potential regulatory moves in the autonomous vehicle sector.

24 lug 2026, 22:02 UTC

News

ServiceNow shares are lower in after-market trading despite reporting $4 billion in revenue and raising full-year subscription guidance amid ongoing sector concerns.

24 lug 2026, 22:01 UTC

News
Social Media

Booz Allen Hamilton reported Q1 fiscal 2027 adjusted EPS of $1.81, exceeding expectations, and provided optimistic revenue guidance, boosting shares higher in after-market hours.

24 lug 2026, 21:41 UTC

News

Tractor Supply Co shares are lower in after-market hours, continuing a decline amid broader market volatility linked to geopolitical tensions and oil supply concerns.

24 lug 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

24 lug 2026, 21:01 UTC

News

Golub Capital Bdc Inc reported a net asset value of $4.5 billion and is conducting a public offering of up to $10 billion in shares.

24 lug 2026, 21:01 UTC

News

Hercules Capital Inc's shares are lower after the company closed a $325 million note offering, with proceeds for debt repayment and investments.

24 lug 2026, 21:01 UTC

News

MetroCity Bankshares reported second-quarter net income of $22.1 million, missing expectations. Shares are higher in after-market trading, continuing a recent upward trend.

24 lug 2026, 20:07 UTC

Social Media
Correlated Moves
News

iShares Core U.S. Aggregate Bond ETF is gaining as major indices rebound amid lower crude oil prices and inflation concerns. The ETF's yield is 4.99%.

24 lug 2026, 20:07 UTC

News
Correlated Moves

Lovesac Co shares are lower as analysts express skepticism, citing slow revenue growth and weak free cash flow margins. The consensus price target is $24.17.

Confronto tra pari

Modifica del prezzo

Hutchison China MediTech Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

35.06% in crescita

Previsioni per 12 mesi

Media 14.87 USD  35.06%

Alto 17 USD

Basso 13.6 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hutchison China MediTech Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

1

Acquista

2

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat